Mark Johnson
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 8
- HIV Research and Treatment 8
-
- HIV/AIDS drug development and treatment 10
- SARS-CoV-2 detection and testing 3
- Co-authors
- Arnold Fridland (6 shared papers)Rodney Croteau (4 shared papers)David R. Appleton (1 shared paper)Andrew Weightman (1 shared paper)József Péter Polgár (1 shared paper)Katy H. P. Moore (2 shared papers)Rodney Croteau (2 shared papers)Dana M. Johnson (5 shared papers)
- Journals
- Biochemical Pharmacology (3 papers)Spinal Cord (2 papers)American Journal of Roentgenology (2 papers)Academic Emergency Medicine (2 papers)Macromolecules (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mark Johnson
70 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 175
- Virology 433
- Infectious Diseases 729
- Clinical Biochemistry 183
- Hepatology 187
- Emergency Medicine 166
Countries citing papers authored by Mark Johnson
This map shows the geographic impact of Mark Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Johnson more than expected).
Fields of papers citing papers by Mark Johnson
This network shows the impact of papers produced by Mark Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Johnson. The network helps show where Mark Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 295 | |
| 2 | 1973 | 276 | |
| 3 | 1999 | 242 | |
| 4 | 2011 | 232 | |
| 5 | 1989 | 163 | |
| 6 | 1998 | 160 | |
| 7 | 2009 | 141 | |
| 8 | 1993 | 138 | |
| 9 | 1988 | 118 | |
| 10 | 2012 | 109 | |
| 11 | 1995 | 106 | |
| 12 | 1987 | 97 | |
| 13 | 1998 | 88 | |
| 14 | 1994 | 88 | |
| 15 | 1987 | 82 | |
| 16 | 1977 | 72 | |
| 17 | 2007 | 71 | |
| 18 | 1995 | 69 | |
| 19 | 1984 | 66 | |
| 20 | 1995 | 59 |
About Mark Johnson
Mark Johnson is a scholar working on Virology, Infectious Diseases, Molecular Biology, Polymers and Plastics and Management Information Systems, having authored 73 papers that have together received 3.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (8 papers), Plant biochemistry and biosynthesis (5 papers), Biochemical and Molecular Research (4 papers), SARS-CoV-2 detection and testing (3 papers), Advanced Polymer Synthesis and Characterization (3 papers), Muscle activation and electromyography studies (3 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Virology (433 citations), Infectious Diseases (729 citations), Clinical Biochemistry (183 citations), Hepatology (187 citations) and Emergency Medicine (166 citations). Mark Johnson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Arnold Fridland, Rodney Croteau, David R. Appleton, Andrew Weightman, József Péter Polgár, Katy H. P. Moore, Rodney Croteau, Dana M. Johnson, Gary E. Pakes and Geoffrey J. Yuen. Their work appears in journals such as Biochemical Pharmacology, Spinal Cord, American Journal of Roentgenology, Academic Emergency Medicine and Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.